| Year |
Citation |
Score |
| 2023 |
Bernal J, Schreiber S, Menze I, Ostendorf A, Pfister M, Geisendörfer J, Nemali A, Maass A, Yakupov R, Peters O, Preis L, Schneider L, Herrera AL, Priller J, Spruth EJ, et al. Arterial hypertension and β-amyloid accumulation have spatially overlapping effects on posterior white matter hyperintensity volume: a cross-sectional study. Alzheimer's Research & Therapy. 15: 97. PMID 37226207 DOI: 10.1186/s13195-023-01243-4 |
0.382 |
|
| 2023 |
Veréb D, Mijalkov M, Chang YW, Canal-Garcia A, Gomez-Ruis E, Maass A, Villeneuve S, Volpe G, Pereira JB. Functional gradients of the medial parietal cortex in a healthy cohort with family history of sporadic Alzheimer's disease. Alzheimer's Research & Therapy. 15: 82. PMID 37076873 DOI: 10.1186/s13195-023-01228-3 |
0.643 |
|
| 2023 |
Heinzinger N, Maass A, Berron D, Yakupov R, Peters O, Fiebach J, Villringer K, Preis L, Priller J, Spruth EJ, Altenstein S, Schneider A, Fliessbach K, Wiltfang J, Bartels C, et al. Exploring the ATN classification system using brain morphology. Alzheimer's Research & Therapy. 15: 50. PMID 36915139 DOI: 10.1186/s13195-023-01185-x |
0.343 |
|
| 2023 |
Brosseron F, Maass A, Kleineidam L, Ravichandran KA, Kolbe CC, Wolfsgruber S, Santarelli F, Häsler LM, McManus R, Ising C, Röske S, Peters O, Cosma NC, Schneider LS, Wang X, et al. Serum IL-6, sAXL, and YKL-40 as systemic correlates of reduced brain structure and function in Alzheimer's disease: results from the DELCODE study. Alzheimer's Research & Therapy. 15: 13. PMID 36631909 DOI: 10.1186/s13195-022-01118-0 |
0.452 |
|
| 2022 |
Parent JH, Ciampa CJ, Harrison TM, Adams JN, Zhuang K, Betts MJ, Maass A, Winer JR, Jagust WJ, Berry AS. Locus coeruleus catecholamines link neuroticism and vulnerability to tau pathology in aging. Neuroimage. 119658. PMID 36191755 DOI: 10.1016/j.neuroimage.2022.119658 |
0.694 |
|
| 2022 |
Billette OV, Ziegler G, Aruci M, Schütze H, Kizilirmak JM, Richter A, Altenstein S, Bartels C, Brosseron F, Cardenas-Blanco A, Dahmen P, Dechent P, Dobisch L, Fliessbach K, Freiesleben SD, ... ... Maass A, et al. Novelty-Related fMRI Responses of Precuneus and Medial Temporal Regions in Individuals at Risk for Alzheimer Disease. Neurology. 99: e775-e788. PMID 35995589 DOI: 10.1212/WNL.0000000000200667 |
0.45 |
|
| 2022 |
Weigand AJ, Maass A, Eglit GL, Bondi MW. What's the cut-point?: a systematic investigation of tau PET thresholding methods. Alzheimer's Research & Therapy. 14: 49. PMID 35382866 DOI: 10.1186/s13195-022-00986-w |
0.443 |
|
| 2022 |
Düzel E, Ziegler G, Berron D, Maass A, Schütze H, Cardenas-Blanco A, Glanz W, Metzger C, Dobisch L, Reuter M, Spottke A, Brosseron F, Fliessbach K, Heneka MT, Laske C, et al. Amyloid pathology but not APOE ε4 status is permissive for tau-related hippocampal dysfunction. Brain : a Journal of Neurology. PMID 35352105 DOI: 10.1093/brain/awab405 |
0.565 |
|
| 2022 |
Ciampa CJ, Parent JH, Harrison TM, Fain RM, Betts MJ, Maass A, Winer JR, Baker SL, Janabi M, Furman DJ, D'Esposito M, Jagust WJ, Berry AS. Associations among locus coeruleus catecholamines, tau pathology, and memory in aging. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 35034099 DOI: 10.1038/s41386-022-01269-6 |
0.742 |
|
| 2021 |
Brosseron F, Maass A, Kleineidam L, Ravichandran KA, González PG, McManus RM, Ising C, Santarelli F, Kolbe CC, Häsler LM, Wolfsgruber S, Marquié M, Boada M, Orellana A, de Rojas I, et al. Soluble TAM receptors sAXL and sTyro3 predict structural and functional protection in Alzheimer's disease. Neuron. PMID 34995486 DOI: 10.1016/j.neuron.2021.12.016 |
0.716 |
|
| 2021 |
Adams JN, Harrison TM, Maass A, Baker SL, Jagust WJ. Distinct factors drive the spatiotemporal progression of tau pathology in older adults. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. PMID 34965972 DOI: 10.1523/JNEUROSCI.1601-21.2021 |
0.639 |
|
| 2021 |
Grande X, Berron D, Maass A, Bainbridge WA, Düzel E. Content-specific vulnerability of recent episodic memories in Alzheimer's disease. Neuropsychologia. 160: 107976. PMID 34314781 DOI: 10.1016/j.neuropsychologia.2021.107976 |
0.312 |
|
| 2021 |
Cassady KE, Adams JN, Chen X, Maass A, Harrison TM, Landau S, Baker S, Jagust W. Alzheimer's Pathology Is Associated with Dedifferentiation of Intrinsic Functional Memory Networks in Aging. Cerebral Cortex (New York, N.Y. : 1991). PMID 34037210 DOI: 10.1093/cercor/bhab122 |
0.727 |
|
| 2021 |
Adams JN, Maass A, Berron D, Harrison TM, Baker SL, Thomas WP, Stanfill M, Jagust WJ. Reduced repetition suppression in aging is driven by tau-related hyperactivity in medial temporal lobe. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. PMID 33731446 DOI: 10.1523/JNEUROSCI.2504-20.2021 |
0.649 |
|
| 2020 |
Young PNE, Estarellas M, Coomans E, Srikrishna M, Beaumont H, Maass A, Venkataraman AV, Lissaman R, Jiménez D, Betts MJ, McGlinchey E, Berron D, O'Connor A, Fox NC, Pereira JB, et al. Imaging biomarkers in neurodegeneration: current and future practices. Alzheimer's Research & Therapy. 12: 49. PMID 32340618 DOI: 10.1186/S13195-020-00612-7 |
0.603 |
|
| 2019 |
Schöll M, Maass A. Does early cognitive decline require the presence of both tau and amyloid-β? Brain : a Journal of Neurology. 143: 10-13. PMID 31886490 DOI: 10.1093/Brain/Awz399 |
0.636 |
|
| 2019 |
Harrison TM, Maass A, Adams JN, Du R, Baker SL, Jagust WJ. Tau deposition is associated with functional isolation of the hippocampus in aging. Nature Communications. 10: 4900. PMID 31653847 DOI: 10.1038/S41467-019-12921-Z |
0.557 |
|
| 2019 |
Adams JN, Maass A, Harrison TM, Baker SL, Jagust WJ. Cortical tau deposition follows patterns of entorhinal functional connectivity in aging. Elife. 8. PMID 31475904 DOI: 10.7554/Elife.49132 |
0.621 |
|
| 2019 |
Betts MJ, Kirilina E, Otaduy MCG, Ivanov D, Acosta-Cabronero J, Callaghan MF, Lambert C, Cardenas-Blanco A, Pine K, Passamonti L, Loane C, Keuken MC, Trujillo P, Lüsebrink F, Mattern H, et al. Locus coeruleus imaging as a biomarker for noradrenergic dysfunction in neurodegenerative diseases. Brain : a Journal of Neurology. PMID 31327002 DOI: 10.1093/Brain/Awz193 |
0.33 |
|
| 2019 |
Winer JR, Mander BA, Helfrich RF, Maass A, Harrison TM, Baker SL, Knight RT, Jagust WJ, Walker MP. Sleep as a potential biomarker of tau and β-amyloid burden in the human brain. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. PMID 31209175 DOI: 10.1523/Jneurosci.0503-19.2019 |
0.522 |
|
| 2019 |
Maass A, Berron D, Harrison TM, Adams JN, La Joie R, Baker S, Mellinger T, Bell RK, Swinnerton K, Inglis B, Rabinovici GD, Düzel E, Jagust WJ. Alzheimer's pathology targets distinct memory networks in the ageing brain. Brain : a Journal of Neurology. PMID 31199481 DOI: 10.1093/Brain/Awz154 |
0.664 |
|
| 2019 |
Baker SL, Harrison TM, Maaß A, La Joie R, Jagust W. Effect of off-target binding on F-Flortaucipir variability in healthy controls across the lifespan. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. PMID 30877180 DOI: 10.2967/Jnumed.118.224113 |
0.473 |
|
| 2018 |
Harrison TM, La Joie R, Maass A, Baker SL, Swinnerton K, Fenton L, Mellinger TJ, Edwards L, Pham J, Miller BL, Rabinovici GD, Jagust WJ. Longitudinal tau accumulation and atrophy in aging and Alzheimer's disease. Annals of Neurology. PMID 30597624 DOI: 10.1002/Ana.25406 |
0.633 |
|
| 2018 |
Schöll M, Maass A, Mattsson N, Ashton NJ, Blennow K, Zetterberg H, Jagust W. Biomarkers for tau pathology. Molecular and Cellular Neurosciences. PMID 30529601 DOI: 10.1016/J.Mcn.2018.12.001 |
0.695 |
|
| 2018 |
Leal SL, Lockhart SN, Maass A, Bell RK, Jagust WJ. Subthreshold amyloid predicts tau deposition in aging. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. PMID 29686045 DOI: 10.1523/Jneurosci.0485-18.2018 |
0.745 |
|
| 2018 |
Harrison TM, Maass A, Baker SL, Jagust WJ. Brain morphology, cognition, and β-amyloid in older adults with superior memory performance. Neurobiology of Aging. 67: 162-170. PMID 29665578 DOI: 10.1016/J.Neurobiolaging.2018.03.024 |
0.512 |
|
| 2017 |
La Joie R, Bejanin A, Fagan AM, Ayakta N, Baker SL, Bourakova V, Boxer AL, Cha J, Karydas A, Jerome G, Maass A, Mensing A, Miller ZA, O'Neil JP, Pham J, et al. Associations between [18F]AV1451 tau PET and CSF measures of tau pathology in a clinical sample. Neurology. PMID 29282337 DOI: 10.1212/Wnl.0000000000004860 |
0.536 |
|
| 2017 |
Winer JR, Maass A, Pressman P, Stiver J, Schonhaut DR, Baker SL, Kramer J, Rabinovici GD, Jagust WJ. Associations Between Tau, β-Amyloid, and Cognition in Parkinson Disease. Jama Neurology. PMID 29228071 DOI: 10.1001/Jamaneurol.2017.3713 |
0.525 |
|
| 2017 |
Maass A, Lockhart SN, Harrison TM, Bell RK, Mellinger T, Swinnerton K, Baker SL, Rabinovici GD, Jagust WJ. Entorhinal tau pathology, episodic memory decline and neurodegeneration in aging. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. PMID 29192126 DOI: 10.1523/Jneurosci.2028-17.2017 |
0.756 |
|
| 2017 |
Baker SL, Maass A, Jagust WJ. Considerations and code for partial volume correcting [(18)F]-AV-1451 tau PET data. Data in Brief. 15: 648-657. PMID 29124088 DOI: 10.1016/J.Dib.2017.10.024 |
0.509 |
|
| 2017 |
Maass A, Landau S, Baker SL, Horng A, Lockhart SN, Joie R, Rabinovici GD, Jagust WJ. Comparison of multiple tau-PET measures as biomarkers in aging and Alzheimer's Disease. Neuroimage. PMID 28587897 DOI: 10.1016/J.Neuroimage.2017.05.058 |
0.768 |
|
| Show low-probability matches. |